Teresa Klinowska
3PUBLICATIONS
66CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Jan 21, 2026
Open-Label Study Assessing Relative and Absolute Bioavailability of Oral Camizestrant Formulations and Food Effects in Healthy Postmenopausal Women.Andy Sykes, Helena Engman, Nigel Taylor
|Aug 11, 2025
Camizestrant in Combination with Three Globally Approved CDK4/6 Inhibitors in Women with ER+, HER2- Advanced Breast Cancer: Results from SERENA-1.Richard D Baird, Begoña Bermejo de Las Heras, Manuel Ruiz-Borrego
|Sep 19, 2023
The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor Resistance.Mandy Lawson, Natalie Cureton, Susana Ros
Pageof 1
Frequent Collaborators
3 joint publications
Justin P O Lindemann
2 joint publications
Andy Sykes
2 joint publications
Alastair M Mathewson
2 joint publications
Christopher J Morrow
2 joint publications
Eric T Gangl
1 joint publications
Natalie Cureton
1 joint publications
Susana Ros
1 joint publications
John McDermott
1 joint publications
Jelena Urosevic
1 joint publications
Sophie D'Arcy
